Hugan Buzure Induces Autophagy and Apoptosis in Hepatocellular Carcinoma by Inhibiting PI3K/Akt/mTOR Signaling Pathway

被引:0
|
作者
Meng, Xiaoyi [1 ]
Li, Min [1 ]
Qiao, Ming [2 ]
Li, Xue [1 ]
Yang, Jianhua [1 ,2 ]
Hu, Junping [1 ]
机构
[1] Xinjiang Med Univ, Coll Pharm, Urumqi 830017, Peoples R China
[2] Xinjiang Med Univ, Dept Pharm, Affiliated Hosp 1, Urumqi 830054, Peoples R China
基金
中国国家自然科学基金;
关键词
CELL; PROGRESSION; MECHANISMS; EXERTS;
D O I
10.1155/2022/1618491
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
This study explored the effects of Hugan Buzure (HBR) on cell apoptosis and autophagy in hepatocellular carcinoma (HCC) and the molecular mechanisms of the PI3K/Akt/mTOR signaling pathway. HepG2 and Huh7 cell viability was detected by the tetramethylazolium salt colorimetric (MTT) method. Cell proliferation was measured using the colony formation method. Hoechst 33258 staining and Aow cytometry were employed to detect apoptosis. In addition, immunoAuorescence was carried out to evaluate the expression of LC3. Western blot was performed to detect the expression of Bcl-2, Bax, Caspase-3, LC3, Beclin1, p62 (SQSTM1), and PI3K/Akt/mTOR signal pathway-related proteins in HCC cells. This work veriDed that HBR reduced HepG2 and Huh7 cell proliferation in a concentration-dependent manner. Treatment with HBR caused an obvious improvement of the apoptosis rate, accompanied by the increase in Bax/Bcl2, Caspase3, LC3II, and Beclin1 levels, respectively. Furthermore, HBR downregulated the expression of p62, p-PI3K, p-Akt, and p-mTOR proteins. HBR combined with HCQ enhanced HBR-induced apoptosis. In conclusion, HBR induced autophagy and apoptosis through PI3K/Akt/mTOR signaling pathway, leading to HCC cell death..is research preliminarily suggested the potential role of HBR in the treatment of HCC.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Rapamycin reduces podocyte damage by inhibiting the PI3K/AKT/mTOR signaling pathway and promoting autophagy
    Yu, Shengyou
    Ren, Qi
    Chen, Jing
    Huang, Jing
    Liang, Rui
    EUROPEAN JOURNAL OF INFLAMMATION, 2022, 20
  • [32] Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma
    Bang, Jieun
    Jun, Mihyeon
    Lee, Soyun
    Moon, Hyuk
    Ro, Simon Weonsang
    PHARMACEUTICS, 2023, 15 (08)
  • [33] The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism
    Tian, Ling-Yu
    Smit, Daniel J.
    Juecker, Manfred
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [34] Dasatinib induces apoptosis and autophagy by suppressing the PI3K/Akt/mTOR pathway in bladder cancer cells
    Ho, Jin-Nyoung
    Byun, Seok-Soo
    Kim, Danhyo
    Ryu, Hoyoung
    Lee, Sangchul
    INVESTIGATIVE AND CLINICAL UROLOGY, 2024, 65 (06) : 593 - 602
  • [35] Ruscogenin suppressed the hepatocellular carcinoma metastasis via PI3K/Akt/mTOR signaling pathway
    Hua, Hui
    Zhu, Yu
    Song, Yu-He
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 101 : 115 - 122
  • [36] Ginsenoside Rg5 induces NSCLC cell apoptosis and autophagy through PI3K/Akt/mTOR signaling pathway
    Zhang, Caidie
    Jin, Yan
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2024, 43
  • [37] Myricetin induces apoptosis and autophagy by inhibiting PI3K/Akt/mTOR signalling in human colon cancer cells
    Zhu, Ming-liang
    Zhang, Pei-min
    Jiang, Min
    Yu, Shu-wen
    Wang, Lu
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2020, 20 (01) : 209
  • [38] Eriodictyol modulates glioma cell autophagy and apoptosis by inhibition of PI3K/Akt/mTOR signaling pathway
    Zeng, Lang
    Fan, Wen
    Tao, Liang
    Cao, Song
    Wang, Yuefei
    Tul, Qin
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2020, 19 (11) : 2329 - 2336
  • [39] Myricetin induces apoptosis and autophagy by inhibiting PI3K/Akt/mTOR signalling in human colon cancer cells
    Ming-liang Zhu
    Pei-min Zhang
    Min Jiang
    Shu-wen Yu
    Lu Wang
    BMC Complementary Medicine and Therapies, 20
  • [40] Tizoxanide induces autophagy by inhibiting PI3K/Akt/mTOR pathway in RAW264.7 macrophage cells
    Jiaoqin Shou
    Mi Wang
    Xiaolei Cheng
    Xiaoyang Wang
    Lifang Zhang
    Yingchun Liu
    Chenzhong Fei
    Chunmei Wang
    Feng Gu
    Feiqun Xue
    Juan Li
    Keyu Zhang
    Archives of Pharmacal Research, 2020, 43 : 257 - 270